ADMA Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,732	4,054	1,021	857	276	184
Market Cap Growth	-5.53%	296.93%	19.17%	210.44%	49.75%	-22.30%
Enterprise Value	3,754	4,079	1,100	975	343	225
Last Close Price	15.68	17.15	4.52	3.88	1.41	1.95
PE Ratio	18.32	20.51	-	-	-	-
Forward PE	19.01	25.28	36.16	-	-	-
PS Ratio	7.64	9.51	3.96	5.56	3.41	4.37
PB Ratio	8.67	11.62	7.55	5.64	1.96	2.09
P/TBV Ratio	8.74	11.75	7.79	5.81	2.03	2.24
P/FCF Ratio	91.63	36.71	253.51	-	-	-
P/OCF Ratio	57.44	34.16	116.07	-	-	-
EV/Sales Ratio	7.68	9.56	4.26	6.33	4.24	5.33
EV/EBITDA Ratio	21.45	27.74	33.58	-	-	-
EV/EBIT Ratio	22.47	29.35	45.03	-	-	-
EV/FCF Ratio	92.17	36.93	273.07	-	-	-
Debt / Equity Ratio	0.19	0.24	1.05	1.02	0.73	1.11
Debt / EBITDA Ratio	0.47	0.55	4.02	-	-	-
Debt / FCF Ratio	2.04	0.74	35.10	-	-	-
Net Debt / Equity Ratio	0.05	-0.06	0.67	0.45	0.37	0.47
Net Debt / EBITDA Ratio	0.12	-0.14	2.75	-2.11	-0.99	-0.78
Net Debt / FCF Ratio	0.53	-0.19	22.35	-0.92	-0.41	-0.36
Asset Turnover	1.02	1.04	0.76	0.49	0.34	0.25
Inventory Turnover	1.20	1.21	1.00	0.83	0.77	0.80
Quick Ratio	3.52	2.76	1.58	2.60	2.62	3.47
Current Ratio	7.13	5.97	5.16	6.89	6.87	7.71
Return on Equity (ROE)	63.17%	81.64%	-19.67%	-44.96%	-62.46%	-132.38%
Return on Assets (ROA)	21.76%	21.24%	4.51%	-7.88%	-14.87%	-21.44%
Return on Capital Employed (ROCE)	32.60%	32.10%	8.70%	-12.70%	-23.40%	-30.60%
Earnings Yield	5.61%	4.88%	-2.77%	-7.69%	-25.95%	-41.09%
FCF Yield	1.09%	2.72%	0.39%	-8.57%	-45.59%	-62.23%
Buyback Yield / Dilution	-3.49%	-8.65%	-13.19%	-41.77%	-62.03%	-58.51%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q